Type 3 secretion effectors

Escherichia coli: Pathotypes and Principles of Pathogenesis: Second Edition

Volumn , Issue , 2013, Pages 451-497

  Clements, Abigail ^a   Berger, Cedric N ^a   Lomma, Mariella ^a   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell survival; Cytoskeleton; Enterohemorrhagic E. coli (EHEC); Enteropathogenic E. coli (EPEC); Escherichia coli; Gut integrity; Immune response; Shigella, type 3 secretion system (T3SS)

Indexed keywords

EID: 84941709852     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397048-0.00015-2     Document Type: Chapter

References (196)

1. Alto N.M., Shao F., Lazar C.S., et al. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 2006, 124(1):133-145.
2. Alto N.M., Weflen A.W., Rardin M.J., et al. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol. 2007, 178(7):1265-1278.
3. Arbeloa A., Bulgin R.R., MacKenzie G., et al. Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell Microbiol. 2008, 10(7):1429-1441.
4. Arbibe L., Kim D.W., Batsche E., et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immun. 2007, 8(1):47-56.
5. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 2010, 12(1):66-73. sup pp. 61-69.
6. Ashida H., Ogawa M., Mimuro H., Kobayashi T., Sanada T., Sasakawa C. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr. Opin. Immunol. 2011, 23(4):448-455.
7. Baruch K., Gur-Arie L., Nadler C. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J. 2011, 30(1):221-231.
8. Batchelor M., Guignot J., Patel A. Involvement of the intermediate filament protein cytokeratin-18 in actin pedestal formation during EPEC infection. EMBO reports 2004, 5(1):104-110.
9. Berger C.N., Crepin V.F., Jepson M.A., Arbeloa A., Frankel G. The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell Microbiol. 2009, 11(2):309-322.
10. Bergounioux J., Elisee R., Prunier A.L. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche. Cell Host Microbe 2012, 11(3):240-252.
11. Bourdet-Sicard R., Rudiger M., Jockusch B.M., Gounon P., Sansonetti P.J., Nhieu G.T. Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 1999, 18(21):5853-5862.
12. Brady M.J., Campellone K.G., Ghildiyal M., Leong J.M. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell Microbiol. 2007, 9(9):2242-2253.
13. Buchwald G., Friebel A., Galan J.E., Hardt W.D., Wittinghofer A., Scheffzek K. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 2002, 21(13):3286-3295.
14. Bulgin R., Raymond B., Garnett J.A. Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect. Immun. 2010, 78(4):1417-1425.
15. Bulgin R.R., Arbeloa A., Chung J.C., Frankel G. EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42. Cell. Microbiol. 2009, 11(2):217-229.
16. Cai S., Bulus N., Fonseca-Siesser P.M. CD98 modulates integrin beta1 function in polarized epithelial cells. J. Cell Sci. 2005, 118(Pt 5):889-899.
17. Campellone K.G., Giese A., Tipper D.J., Leong J.M. A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol. Microbiol. 2002, 43(5):1227-1241.
18. Campellone K.G., Leong J.M. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol. Microbiol. 2005, 56(2):416-432.
19. Campellone K.G., Robbins D., Leong J.M. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev. Cell 2004, 7(2):217-228.
20. Caron E., Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998, 282(5394):1717-1721.
21. Celli J., Olivier M., Finlay B.B. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 2001, 20(6):1245-1258.
22. Chakravortty D., Kumar K.S. Interaction of lipopolysaccharide with human small intestinal lamina propria fibroblasts favors neutrophil migration and peripheral blood mononuclear cell adhesion by the production of proinflammatory mediators and adhesion molecules. Biochim. Biophys. Acta 1999, 1453(2):261-272.
23. Chen L., Fischle W., Verdin E., Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001, 293(5535):1653-1657.
24. Chen Y., Smith M.R., Thirumalai K., Zychlinsky A. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 1996, 15(15):3853-3860.
25. Cheng H.C., Skehan B.M., Campellone K.G., Leong J.M., Rosen M.K. Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). Nature 2008, 454(7207):1009-1013.
26. Clements A., Smollett K., Lee S.F., Hartland E.L., Lowe M., Frankel G. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function. Cell. Microbiol. 2011, 13(9):1429-1439.
27. Crepin V.F., Girard F., Schuller S., Phillips A.D., Mousnier A., Frankel G. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo. Mol. Microbiol. 2010, 75(2):308-323.
28. Cui J., Yao Q., Li S. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 2010, 329(5996):1215-1218.
29. Davis J., Wang J., Tropea J.E. Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri. Protein Sci. 2008, 17(12):2167-2173.
30. Dean P., Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 2004, 54(3):665-675.
31. Dean P., Maresca M., Schuller S., Phillips A.D., Kenny B. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl. Acad. Sci. USA 2006, 103(6):1876-1881.
32. Dean P., Muhlen S., Quitard S., Kenny B. The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector. Cell. Microbiol. 2010, 12(9):1308-1321.
33. Deng L., Wang C., Spencer E. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103(2):351-361.
34. Deng W., Puente J.L., Gruenheid S. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. USA 2004, 101(10):3597-3602.
35. Deng W., Yu H.B., de Hoog C.L. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens. Mol. Cell. Proteomics MCP 2012, 11(9):692-709.
36. Domingo-Sananes M.R., Kapuy O., Hunt T., Novak B. Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis. Philosophical transactions of the Royal Society of London. Ser. B. Biol. Sci. 2011, 366(1584):3584-3594.
37. Dong N., Liu L., Shao F. A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis. EMBO J. 2010, 29(9):1363-1376.
38. Dong N., Zhu Y., Lu Q., Hu L., Zheng Y., Shao F. Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 2012, 150(5):1029-1041.
39. Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., Schulman B.A. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134(6):995-1006.
40. Dumenil G., Olivo J.C., Pellegrini S., Fellous M., Sansonetti P.J., Nhieu G.T. Interferon alpha inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J. Cell Biol. 1998, 143(4):1003-1012.
41. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 2006, 22(2):245-257.
42. Frankel G., Lider O., Hershkoviz R. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J. Biol. Chem. 1996, 271(34):20359-20364.
43. Freeman N.L., Zurawski D.V., Chowrashi P. Interaction of the enteropathogenic Escherichia coli protein, translocated intimin receptor (Tir), with focal adhesion proteins. Cell Motil. Cytoskeleton 2000, 47(4):307-318.
44. Gao X., Wan F., Mateo K. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog. 2009, 5(12):e1000708.
45. Garmendia J., Carlier M.F., Egile C., Didry D., Frankel G. Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection. Cell. Microbiol. 2006, 8(9):1444-1455.
46. Garmendia J., Phillips A.D., Carlier M.F. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell. Microbiol. 2004, 6(12):1167-1183.
47. Germane K.L., Ohi R., Goldberg M.B., Spiller B.W. Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules. Biochemistry 2008, 47(39):10241-10243.
48. Gill R.K., Borthakur A., Hodges K. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J. Clin. Invest. 2007, 117(2):428-437.
49. Goosney D.L., Celli J., Kenny B., Finlay B.B. Enteropathogenic Escherichia coli inhibits phagocytosis. Infect. Immun. 1999, 67(2):490-495.
50. Goosney D.L., DeVinney R., Finlay B.B. Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals. Infect. Immun. 2001, 69(5):3315-3322.
51. Gruenheid S., DeVinney R., Bladt F. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat. Cell Biol. 2001, 3(9):856-859.
52. Guttman J.A., Lin A.E., Veiga E., Cossart P., Finlay B.B. Role for CD2AP and other endocytosis-associated proteins in enteropathogenic Escherichia coli pedestal formation. Infect. Immun. 2010, 78(8):3316-3322.
53. Guttman J.A., Samji F.N., Li Y., Deng W., Lin A., Finlay B.B. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell. Microbiol. 2007, 9(1):131-141.
54. Hachani A., Biskri L., Rossi G. IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexneri. Microbes Infect. 2008, 10(3):260-268.
55. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279(5350):509-514.
56. Hall A. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 2005, 33(Pt 5):891-895.
57. Hamaguchi M., Hamada D., Suzuki K.N., Sakata I., Yanagihara I. Molecular basis of actin reorganization promoted by binding of enterohaemorrhagic Escherichia coli EspB to alpha-catenin. FEBS J. 2008, 275(24):6260-6267.
58. Handa Y., Suzuki M., Ohya K. Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat. Cell Biol. 2007, 9(1):121-128.
59. Hauf N., Chakraborty T. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J. Immunol. 2003, 170(4):2074-2082.
60. Hecht G., Hodges K., Gill R.K. Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E. coli in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287(2):G370-G378.
61. Hemrajani C., Berger C.N., Robinson K.S., Marches O., Mousnier A., Frankel G. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. USA 2010, 107(7):3129-3134.
62. Hilbi H., Moss J.E., Hersh D. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 1998, 273(49):32895-32900.
63. Hodges K., Alto N.M., Ramaswamy K., Dudeja P.K., Hecht G. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell. Microbiol. 2008, 10(8):1735-1745.
64. Hsu Y., Jubelin G., Taieb F., Nougayrede J.P., Oswald E., Stebbins C.E. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J. Mol. Biol. 2008, 384(2):465-477.
65. Huang Z., Sutton S.E., Wallenfang A.J. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat. Struct. Mol. Biol. 2009, 16(8):853-860.
66. Iguchi A., Thomson N.R., Ogura Y. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J. Bacteriol. 2009, 191(1):347-354.
67. Iizumi Y., Sagara H., Kabe Y. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2007, 2(6):383-392.
68. Isberg R.R., Leong J.M. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990, 60(5):861-871.
69. Iwai H., Kim M., Yoshikawa Y. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 2007, 130(4):611-623.
70. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7(3):279-296.
71. Jubelin G., Taieb F., Duda D.M. Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog. 2010, 6(9):e1001128.
72. Kanayama A., Seth R.B., Sun L. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 2004, 15(4):535-548.
73. Kanneganti T.D., Lamkanfi M., Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007, 27(4):549-559.
74. Kayath C.A., Hussey S., El hajjami N., Nagra K., Philpott D., Allaoui A. Escape of intracellular Shigella from autophagy requires binding to cholesterol through the type III effector, IcsB. Microbes. Infect. Institut. Pasteur. 2010, 12(12-13):956-966.
75. Kelly M., Hart E., Mundy R. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 2006, 74(4):2328-2337.
76. Kenny B., Ellis S., Leard A.D., Warawa J., Mellor H., Jepson M.A. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol. Microbiol. 2002, 44(4):1095-1107.
77. Khan M.A., Ma C., Knodler L.A. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect. Immun. 2006, 74(5):2522-2536.
78. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 2005, 102(39):14046-14051.
79. Kim J., Thanabalasuriar A., Chaworth-Musters T. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2007, 2(3):160-171.
80. Kim M., Ogawa M., Fujita Y. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 2009, 459(7246):578-582.
81. Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34(3):259-269.
82. Klink B.U., Barden S., Heidler T.V. Structure of Shigella IpgB2 in complex with human RhoA: implications for the mechanism of bacterial guanine nucleotide exchange factor mimicry. J. Biol. Chem. 2010, 285(22):17197-17208.
83. Knappstein S., Ide T., Schmidt M.A., Heusipp G. Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains. Infect. Immun. 2004, 72(8):4344-4350.
84. Kodama T., Akeda Y., Kono G., Takahashi A., Imura K., Iida T., Honda T. The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin. Cell. Microbiol. 2002, 4(4):213-222.
85. Kraft C., Peter M., Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nat. Cell Biol. 2010, 12(9):836-841.
86. Kramer R.W., Slagowski N.L., Eze N.A. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 2007, 3(2):e21.
87. Kueltzo L.A., Osiecki J., Barker J. Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri. J. Biol. Chem. 2003, 278(5):2792-2798.
88. Kurushima J., Nagai T., Nagamatsu K., Abe A. EspJ effector in enterohemorrhagic E. coli translocates into host mitochondria via an atypical mitochondrial targeting signal. Microbiol. Immunol. 2010, 54(7):371-379.
89. Lamprecht G., Heil A., Baisch S. The down regulated in adenoma (dra) gene product binds to the second PDZ domain of the NHE3 kinase A regulatory protein (E3KARP), potentially linking intestinal Cl-/HCO3- exchange to Na+/H+ exchange. Biochemistry 2002, 41(41):12336-12342.
90. Lee S.F., Kelly M., McAlister A. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell. Microbiol. 2008, 10(2):499-513.
91. Legate K.R., Montanez E., Kudlacek O., Fassler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell Biol. 2006, 7(1):20-31.
92. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
93. Li H., Xu H., Zhou Y. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315(5814):1000-1003.
94. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2(10):725-734.
95. Mantis N., Prevost M.C., Sansonetti P. Analysis of epithelial cell stress response during infection by Shigella flexneri. Infect. Immun. 1996, 64(7):2474-2482.
96. Marches O., Batchelor M., Shaw R.K. EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J. Bacteriol. 2006, 188(8):3110-3115.
97. Marches O., Covarelli V., Dahan S. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell. Microbiol. 2008, 10(5):1104-1115.
98. Marches O., Ledger T.N., Boury M. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 2003, 50(5):1553-1567.
99. Marches O., Wiles S., Dziva F. Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect. Immun. 2005, 73(12):8411-8417.
100. Maresca M., Miller D., Quitard S., Dean P., Kenny B. Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. Cell Microbiol. 2005, 7(12):1749-1762.
101. Martinez E., Schroeder G.N., Berger C.N. Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. Cell. Microbiol. 2010, 12(12):1718-1731.
102. Matsuzawa T., Kuwae A., Yoshida S., Sasakawa C., Abe A. Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J. 2004, 23(17):3570-3582.
103. McDaniel T.K., Jarvis K.G., Donnenberg M.S., Kaper J.B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 1995, 92(5):1664-1668.
104. Michail S.K., Halm D.R., Abernathy F. Enteropathogenic Escherichia coli: stimulating neutrophil migration across a cultured intestinal epithelium without altering transepithelial conductance. J. Pediatr. Gastroenterol. Nutr. 2003, 36(2):253-260.
105. Miyahara A., Nakanishi N., Ooka T., Hayashi T., Sugimoto N., Tobe T. Enterohemorrhagic Escherichia coli effector EspL2 induces actin microfilament aggregation through annexin 2 activation. Cell. Microbiol. 2009, 11(2):337-350.
106. Morikawa H., Kim M., Mimuro H. The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1. Biochemi. Biophys. Res. Commun. 2010, 401(2):268-274.
107. Mostowy S., Bonazzi M., Hamon M.A. Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe 2010, 8(5):433-444.
108. Mounier J., Popoff M.R., Enninga J., Frame M.C., Sansonetti P.J., Van Nhieu G.T. The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells. PLoS Pathog. 2009, 5(1):e1000271.
109. Mousnier A., Whale A.D., Schuller S., Leong J.M., Phillips A.D., Frankel G. Cortactin recruitment by enterohemorrhagic Escherichia coli O157:H7 during infection in vitro and ex vivo. Infect. Immun. 2008, 76(10):4669-4676.
110. Muhlen S., Ruchaud-Sparagano M.H., Kenny B. Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli. J. Biol. Chem. 2011, 286(7):5100-5107.
111. Nadler C., Baruch K., Kobi S. The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog. 2010, 6(1):e1000743.
112. Nagai T., Abe A., Sasakawa C. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 2005, 280(4):2998-3011.
113. Nataro J.P., Seriwatana J., Fasano A. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect. Immun. 1995, 63(12):4721-4728.
114. Newton H.J., Pearson J.S., Badea L. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog. 2010, 6(5):e1000898.
115. Niebuhr K., Giuriato S., Pedron T. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J. 2002, 21(19):5069-5078.
116. Nougayrede J.P., Donnenberg M.S. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 2004, 6(11):1097-1111.
117. Nougayrede J.P., Foster G.H., Donnenberg M.S. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell. Microbiol. 2007, 9(3):680-693.
118. Ogawa M., Yoshimori T., Suzuki T., Sagara H., Mizushima N., Sasakawa C. Escape of intracellular Shigella from autophagy. Science 2005, 307(5710):727-731.
119. Ogura Y., Ooka T., Whale A. TccP2 of O157:H7 and non-O157 enterohemorrhagic Escherichia coli (EHEC): challenging the dogma of EHEC-induced actin polymerization. Infect. Immun. 2007, 75(2):604-612.
120. Ohlson M.B., Huang Z., Alto N.M. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 2008, 4(5):434-446.
121. Ohya K., Handa Y., Ogawa M., Suzuki M., Sasakawa C. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 2005, 280(25):24022-24034.
122. Orchard R.C., Kittisopikul M., Altschuler S.J., Wu L.F., Suel G.M., Alto N.M. Identification of F-actin as the dynamic hub in a microbial-induced GTPase polarity circuit. Cell 2012, 148(4):803-815.
123. Oswald E., Sugai M., Labigne A. Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc. Natl. Acad. Sci. USA 1994, 91(9):3814-3818.
124. Parsot C. Shigella type III secretion effectors: how, where, when, for what purposes?. Curr. Opin. Microbiol. 2009, 12(1):110-116.
125. Patel A., Cummings N., Batchelor M. Host protein interactions with enteropathogenic Escherichia coli (EPEC): 14-3-3tau binds Tir and has a role in EPEC-induced actin polymerization. Cell. Microbiol. 2006, 8(1):55-71.
126. Pearson J.S., Riedmaier P., Marches O., Frankel G., Hartland E.L. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol. Microbiol. 2011, 80(1):219-230.
127. Peralta-Ramirez J., Hernandez J.M., Manning-Cela R. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect. Immun. 2008, 76(9):3854-3868.
128. Petty N.K., Bulgin R., Crepin V.F. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 2010, 192(2):525-538.
129. Pfleger C.M., Salic A., Lee E., Kirschner M.W. Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Deve. 2001, 15(14):1759-1764.
130. Phillips N., Hayward R.D., Koronakis V. Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation. Nat. Cell Biol. 2004, 6(7):618-625.
131. Quitard S., Dean P., Maresca M., Kenny B. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell. Microbiol. 2006, 8(6):972-981.
132. Raqib R., Ekberg C., Sharkar P. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect. Immun. 2002, 70(6):3199-3207.
133. Raymond B., Crepin V.F., Collins J.W., Frankel G. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-kappaB-dependent manner. Cell. Microbiol. 2011, 13(12):1881-1893.
134. Ritchie J.M., Brady M.J., Riley K.N. EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7. Cell. Microbiol. 2008, 10(4):836-847.
135. Robinson C.M., Sinclair J.F., Smith M.J., O'Brien A.D. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc. Natl. Acad. Sci. USA 2006, 103(25):9667-9672.
136. Robinson K.S., Mousnier A., Hemrajani C., Fairweather N., Berger C.N., Frankel G. The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B. Microbiology 2010, 156(Pt 6):1815-1823.
137. Rohde J.R., Breitkreutz A., Chenal A., Sansonetti P.J., Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007, 1(1):77-83.
138. Romero S., Grompone G., Carayol N. ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells. Cell Host Microbe 2011, 9(6):508-519.
139. Royan S.V., Jones R.M., Koutsouris A. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-kappaB activation. Mol. Microbiol. 2010, 78(5):1232-1245.
140. Sakaguchi T., Kohler H., Gu X., McCormick B.A., Reinecker H.C. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell. Microbiol. 2002, 4(6):367-381.
141. Samba-Louaka A., Nougayrede J.P., Watrin C., Oswald E., Taieb F. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect. Immun. 2009, 77(12):5471-5477.
142. Sanada T., Kim M., Mimuro H. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 2012, 483(7391):623-626.
143. Sason H., Milgrom M., Weiss A.M. Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection. Mol. Biol. Cell 2009, 20(1):544-555.
144. Savkovic S.D., Koutsouris A., Hecht G. Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect. Immun. 1996, 64(11):4480-4487.
145. Schuller S., Chong Y., Lewin J., Kenny B., Frankel G., Phillips A.D. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell. Microbiol. 2007, 9(5):1352-1364.
146. Schuller S., Lucas M., Kaper J.B., Giron J.A., Phillips A.D. The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 2009, 11(3):521-530.
147. Selbach M., Paul F.E., Brandt S. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 2009, 5(4):397-403.
148. Selyunin A.S., Alto N.M. Activation of PAK by a bacterial type III effector EspG reveals alternative mechanisms of GTPase pathway regulation. Small GTPases. 2011, 2(4):217-221.
149. Selyunin A.S., Sutton S.E., Weigele B.A. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 2011, 469(7328):107-111.
150. Sham H.P., Shames S.R., Croxen M.A. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-kappaB and p38 mitogen-activated protein kinase activation. Infect. Immun. 2011, 79(9):3552-3562.
151. Shames S.R., Bhavsar A.P., Croxen M.A. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cell. Microbiol. 2011, 13(10):1542-1557.
152. Shames S.R., Croxen M.A., Deng W., Finlay B.B. The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b. Infect. Immun. 2011, 79(12):4784-4790.
153. Shames S.R., Deng W., Guttman J.A. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell. Microbiol. 2010, 12(9):1322-1339.
154. Shifflett D.E., Clayburgh D.R., Koutsouris A., Turner J.R., Hecht G.A. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab. Invest. 2005, 85(10):1308-1324.
155. Shifrin Y., Kirschner J., Geiger B., Rosenshine I. Enteropathogenic Escherichia coli induces modification of the focal adhesions of infected host cells. Cell. Microbiol. 2002, 4(4):235-243.
156. Silverman N., Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001, 15(18):2321-2342.
157. Simonovic I., Rosenberg J., Koutsouris A., Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell. Microbiol. 2000, 2(4):305-315.
158. Simpson N., Shaw R., Crepin V.F. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Mol. Microbiol. 2006, 60(2):349-363.
159. Singer A.U., Rohde J.R., Lam R. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat. Struct. Mol. Biolo. 2008, 15(12):1293-1301.
160. Smith K., Humphreys D., Hume P.J., Koronakis V. Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 2010, 7(1):13-24.
161. Starostina N.G., Kipreos E.T. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol. 2012, 22(1):33-41.
162. Swanson J.A., Johnson M.T., Beningo K., Post P., Mooseker M., Araki N. A contractile activity that closes phagosomes in macrophages. J. Cell Sci. 1999, 112(Pt 3):307-316.
163. Swimm A., Bommarius B., Li Y. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell. 2004, 15(8):3520-3529.
164. Taylor K.A., Luther P.W., Donnenberg M.S. Expression of the EspB protein of enteropathogenic Escherichia coli within HeLa cells affects stress fibers and cellular morphology. Infect. Immun. 1999, 67(1):120-125.
165. Thanabalasuriar A., Koutsouris A., Weflen A., Mimee M., Hecht G., Gruenheid S. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell. Microbiol. 2010, 12(1):31-41.
166. Tobe T., Beatson S.A., Taniguchi H. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc. Natl. Acad. Sci. USA 2006, 103(40):14941-14946.
167. Tomar A., Schlaepfer D.D. Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. Curr. Opin. Cell Biol. 2009, 21(5):676-683.
168. Touze T., Hayward R.D., Eswaran J., Leong J.M., Koronakis V. Self-association of EPEC intimin mediated by the beta-barrel-containing anchor domain: a role in clustering of the Tir receptor. Mol. Microbiol. 2004, 51(1):73-87.
169. Toyotome T., Suzuki T., Kuwae A. Shigella protein IpaH(9.8) is secreted from bacteria within mammalian cells and transported to the nucleus. J. Biol. Chem. 2001, 276(34):32071-32079.
170. Tran Van Nhieu G., Ben-Ze'ev A., Sansonetti P.J. Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 1997, 16(10):2717-2729.
171. Tran Van Nhieu G., Caron E., Hall A., Sansonetti P.J. IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 1999, 18(12):3249-3262.
172. Tu X., Nisan I., Yona C., Hanski E., Rosenshine I. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol. Microbiol. 2003, 47(3):595-606.
173. Uchiya K., Tobe T., Komatsu K. Identification of a novel virulence gene, virA, on the large plasmid of Shigella, involved in invasion and intercellular spreading. Mol. Microbiol. 1995, 17(2):241-250.
174. Unsworth K.E., Mazurkiewicz P., Senf F. Dynamin is required for F-actin assembly and pedestal formation by enteropathogenic Escherichia coli (EPEC). Cell. Microbiol. 2007, 9(2):438-449.
175. Veiga E., Guttman J.A., Bonazzi M. Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe 2007, 2(5):340-351.
176. Vingadassalom D., Campellone K.G., Brady M.J. Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog. 2010, 6(8):e1001056.
177. Vingadassalom D., Kazlauskas A., Skehan B. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc. Natl. Acad. Sci. USA 2009, 106(16):6754-6759.
178. Viswanathan V.K., Lukic S., Koutsouris A., Miao R., Muza M.M., Hecht G. Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Cell. Microbiol. 2004, 6(10):987-997.
179. Vossenkamper A., Marches O., Fairclough P.D. Inhibition of NF-kappaB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J. Immunol. 2010, 185(7):4118-4127.
180. Wan F., Anderson D.E., Barnitz R.A. Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell 2007, 131(5):927-939.
181. Wan F., Weaver A., Gao X., Bern M., Hardwidge P.R., Lenardo M.J. IKKbeta phosphorylation regulates RPS3 nuclear translocation and NF-kappaB function during infection with Escherichia coli strain O157:H7. Nat. Immun. 2011, 12(4):335-343.
182. Weiss S.M., Ladwein M., Schmidt D. IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe 2009, 5(3):244-258.
183. Whale A.D., Garmendia J., Gomes T.A., Frankel G. A novel category of enteropathogenic Escherichia coli simultaneously utilizes the Nck and TccP pathways to induce actin remodelling. Cell. Microbiol. 2006, 8(6):999-1008.
184. Wong A.R., Clements A., Raymond B., Crepin V.F., Frankel G. The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH. mBio 2012, 3(1). e00250-11.
185. Wong A.R., Raymond B., Collins J.W., Crepin V.F., Frankel G. The enteropathogenic E. coli effector EspH promotes actin pedestal formation and elongation via WASP-interacting protein (WIP). Cell. Microbiol 2012, 14(7):1051-1070.
186. Wu B., Skarina T., Yee A. NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog. 2010, 6(6):e1000960.
187. Wu C.J., Conze D.B., Li T., Srinivasula S.M., Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 2006, 8(4):398-406.
188. Yan Y., Vasudevan S., Nguyen H.T., Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim. Biophys. Acta 2008, 1780(10):1087-1092.
189. Yang Z., Klionsky D.J. Eaten alive: a history of macroautophagy. Nat. Cell. Biol 2010, 12:814-822.
190. Yen H., Ooka T., Iguchi A., Hayashi T., Sugimoto N., Tobe T. NleC, a type III secretion protease, compromises NF-kappaB activation by targeting p65/RelA. PLoS Pathog. 2010, 6(12):e1001231.
191. Yoshida S., Handa Y., Suzuki T. Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science 2006, 314(5801):985-989.
192. Yoshida S., Katayama E., Kuwae A., Mimuro H., Suzuki T., Sasakawa C. Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J. 2002, 21(12):2923-2935.
193. Zhang L., Ding X.J., Cui J. Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappa B activation. Nature 2012, 481(7380):204-208.
194. Zurawski D.V., Mumy K.L., Badea L. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect. Immun. 2008, 76(1):369-379.
195. Zurawski D.V., Mumy K.L., Faherty C.S., McCormick B.A., Maurelli A.T. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol. Microbiol. 2009, 71(2):350-368.
196. Zychlinsky A., Kenny B., Menard R., Prevost M.C., Holland I.B., Sansonetti P.J. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 1994, 11(4):619-627.